Recent Quotes

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Earnings

H1 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-09-08
REV		(EXPECTED)2021-09-08

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
NBTX	Nanobiotix	15.61	-0.39	-2.44%		537.9M

Nanobiotix Frequently Asked Questions

How do I buy Nanobiotix (NBTX) stock?

You can purchase shares of Nanobiotix (NASDAQ: NBTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Nanobiotix's (NBTX) competitors?

Other companies in Nanobiotix’s space includes: Eagle Pharmaceuticals (NASDAQ:EGRX), Altimmune (NASDAQ:ALT), Atossa Therapeutics (NASDAQ:ATOS), Gritstone Bio (NASDAQ:GRTS) and VistaGen Therapeutics (NASDAQ:VTGN).

What is the target price for Nanobiotix (NBTX) stock?

The latest price target for Nanobiotix (NASDAQ: NBTX) was reported by Evercore ISI Group on January 6, 2021. The analyst firm set a price target for 0.00 expecting NBTX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Nanobiotix (NBTX)?

The stock price for Nanobiotix (NASDAQ: NBTX) is $15.61 last updated Fri Jun 11 2021 19:39:29 GMT+0000 (Coordinated Universal Time).

Does Nanobiotix (NBTX) pay a dividend?

There are no upcoming dividends for Nanobiotix.

When is Nanobiotix (NASDAQ:NBTX) reporting earnings?

Nanobiotix’s H1 earnings are confirmed for after-market on September 8, 2021.

Is Nanobiotix (NBTX) going to split?

There is no upcoming split for Nanobiotix.

What sector and industry does Nanobiotix (NBTX) operate in?

Nanobiotix is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.